Down-regulation of estrogen receptor-α in MCF-7 human breast cancer cells after proteasome inhibition
- 作者：Kannan V. Balan ; Yongbao Wang ; Siming W. Chen ; Panayotis Pantazis ; James H. Wyche and Zhiyong Han
- 关键词：Proteasome ; Inhibitor ; Estrogen receptor-α ; down-regulation ; Estrogen
- 刊名：Biochemical Pharmacology
- 出版年：2006
- 期刊代码：2_00062952
- 类别：pha
- 出版时间：28 August 2006
- 卷：72
- 期：5
- 页码：566-572
- 文件大小：516 K
摘要
The eukaryotic proteasome is a 26S ATP-dependent proteolytic complex, which possesses chymotrypsin-like, trypsin-like and peptidyl glutamyl peptide hydrolase (PGPH) activities, which enable the proteasome to degrade all short-lived and many long-lived proteins, and consequently regulate a myriad of activities in cells. In this study, we observed that inhibition of the proteasome, and more specifically, inhibition of the chymotrypsin-like activity of the proteasome, in MCF-7 human breast cancer cells resulted in selective down-regulation of the nuclear estrogen receptor-α (ERα). Our data indicated that estrogen had no effect, whereas the ERα antagonist, tamoxifen, reduced the amount of ERα that could be subjected to down-regulation after proteasome inhibition. Furthermore, our data demonstrated that protein synthesis was required for the down-regulation of ERα to occur. Collectively, these data indicate the existence of a proteasome-dependent mechanism that is utilized by MCF-7 cells to maintain a steady-state level of ERα.